95971 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more P—C bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se); Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic Esters of acyclic acids which can have further substituents on alkyl
Sub-classes:METAL EXTRACTANT, SEPARATION RECOVERY METHOD OF METAL IONS USING METAL EXTRACTANT, AND COMPOUND
#2NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#3MULTIFUNCTIONAL FLUORINATED PHOSPHOROUS COMPOUNDS, METHODS OF MAKING, AND ARTICLES AND USES THEREOF
#4MULTIFUNCTIONAL CONJUGATES
#5METHOD OF PURIFYING PHOSPHORUS COMPOUND AND METHOD OF REUSING THE SAME
#6NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#7ASPARAGINE DERIVATIVES AND METHODS OF USING SAME
#8Ionic liquid including fluorine-containing phosphate ester anions, and lubricating oil composition
#9INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION
#10Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#11PREPARATION OF A P2X3 ANTAGONIST
#12FRICTION MODIFIER COMPOUNDS AND RELATED COMPOSITIONS AND METHODS
#13Multifunctional conjugates
#14Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
#15Methods of synthesizing a difluorolactam analog
#16Beta-hydroxyphosphonate functionalized polyols
#17SEQUESTERING COMPOSITIONS AND MATERIALS
#18TRIPHOSPHONATE COMPOSITIONS, SELF-ASSEMBLED TRIPHOSPHONATE MONOLAYERS, PRODUCTS AND APPARATUS MADE FROM SUCH COMPOSITIONS AND MONOLAYERS, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS, MONOLAYERS, PRODUCTS, AND APPARATUS
#19ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
#20Oligomeric alkoxy amines
#21Surface treatment agent, surface treatment method, and area selective deposition method
#22Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#23Nucleic acid-polypeptide compositions and uses thereof
#24Sequestering compositions and materials
#25Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#26Preparation and use of aminoalkylphosphonic acid dialkyl ester compounds in a lubricant for antiwear, friction reduction, and/or micropitting prevention
#27Multifunctional conjugates
#28Use of novel compounds for selectively extracting rare earths from aqueous solutions including phosphoric acid and associated extraction method
#29TRIFUNCTIONAL ADDITIVES FOR ELECTROLYTE COMPOSITION FOR LITHIUM BATTERIES
#30Inhibitors of creatine transport and uses thereof
#31Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#32Transparent self-healing omniphobic coatings
#33BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#34Methods of synthesizing a difluorolactam analog
#35Method of producing beraprost
#36HIGH REFRACTIVE INDEX LIQUIDS BASED ON META-SUBSTITUTED S-ALKYL THIOETHERS
#37Phosphonate functional antimicrobial coatings for metal surfaces
#38Biodegradable compound, lipid particle, composition containing lipid particle, and kit
#39Aminobisphosphonate antiwear additives
#40Thyroid hormone receptor agonist and use thereof
#41Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials
#42Regulators for controlling linear and pseudo-ring expansion polymerization of vinyl monomers
#43NOVEL ORGANIC MATERIAL FOR EXTRACTING THE URANIUM FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID, ASSOCIATED METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM AND A PRECURSOR OF SUCH AN ORGANIC MATERIAL
#44Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#45Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
#46Method of producing beraprost
#47METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG
#48Use of novel compounds for selectively extracting rare earths from aqueous solutions including phosphoric acid and associated extraction method
#49AUTOTAXIN INHIBITORS AND USES THEREOF
#50Bicyclic aryl sphingosine 1-phosphate analogs
#51Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#52Use of amino-containing neutral phosphine extractant in extraction and separation of thorium and process of using same
#53Bicyclic aryl sphingosine 1-phosphate analogs
#54Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#55Method of producing beraprost
#56Transparent self-healing omniphobic coatings
#57Selective caspase inhibitors and uses thereof
#58Inhibitors of creatine transport and uses thereof
#59Phosphonate functional antimicrobial coatings for metal surfaces
#60Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
#61Phenylcarbamate derivatives as formyl peptide receptor modulators
#62Catalytic hydrogenation for producing amines from carboxylic acid amides, carboxylic acid diamides, di-, tri-, or polypeptides, or peptide amides
#63Phosphonate and phosphonic acid raft agents and monomers, along with methods of their manufacture and use
#64Method of producing beraprost
#65FLUORINATED COMPOUNDS USABLE AS AN ORGANIC SOLVENT FOR LITHIUM SALTS
#66Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
#67Silylalkyloxyaryl compounds and methods for treating cancer
#68REACTIVE FLAME RETARDANTS
#69Bicyclic aryl sphingosine 1-phosphate analogs
#70Phosphorus functional antimicrobial coatings for metal surfaces
#71Methods of synthesizing a difluorolactam analog
#72Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#73Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
#74Phosphonate ester derivatives and methods of synthesis thereof
#75Organophosphorus compounds for flame retardant polyurethane foams
#76Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
#77Phosphorous-containing aluminum carboxylate salt flame retardants
#78Polysilylated organosilane compounds
#79Method of producing beraprost
#80Stable ligand mixtures and processes for making same
#81Process for stabilizing hydrocyanation catalyst
#82Synthesis and antiscalant behavior of a novel polyzwitterionic acid
#83Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof
#844-dedimethylamino tetracycline compounds
#85METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM
#86Phosphonate and phosphonic acid RAFT agents and monomers, along with methods of their manufacture and use
#87Tetra- and pentasubstituted benzimidazolium compounds
#88Benzimidazolium compounds
#89Selective caspase inhibitors and uses thereof
#90Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
#91Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
#92Bicyclic aryl sphingosine 1-phosphate analogs
#93Synthesis of H-phosphonate intermediates and their use in preparing the herbicide glyphosate
#94Method of producing beraprost
#95Non-aqueous electrolyte solution containing phosphonosulfonic acid compound, and lithium secondary battery
#96Surface modified lithium titanate and preparation method thereof
#97Additive for nonaqueous electrolyte, nonaqueous electrolyte, and electricity storage device
#98Beta-hydroxy-gamma-aminophosphonates for treating immune disorders
#99BIFUNCTIONAL CHELATING AGENTS
#100Synthetic lung surfactant and use thereof
#101Non-aqueous electrolyte solution and electricity-storage device using same
#102Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method
#103Surface-modified pigment preparations
#104Aminohydroxylation of alkenes
#105(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
#106Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
#107β-hydroxy-γ-aminophosphonates and methods for the preparation and use thereof
#108Preparation and use of aminoalkylphosphonic acid dilakyl ester compounds in a lubricant for antiwear, friction reduction, and/or micropitting prevention
#109NOVEL MULTIFUNCTIONAL MOLECULES FOR DENTAL BONDING APPLICATIONS HAVING IMPROVED ADHESION
#110PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS
#111Method of producing beraprost
#112Process for the preparation of chymase modulators
#113Intermediate compounds and processes for the preparation of tapentadol and related compounds
#1149-substituted minocycline compounds
#115PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS
#116Process for preparation of HIV protease inhibitors
#117Poly(ethylene glycol) containing chemically disparate endgroups
#118Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
#119Phosphonate bonding compositions
#120Bicyclic aryl sphingosine 1-phosphate analogs
#121FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID
#122Polyfluoroalkylphosphonic acid oxyalkylene ester, method for producing the same, and mold-releasing agent comprising the same as active ingredient
#123Process for manufacturing phosphate esters from phosphoryl chloride and monoalkyl ethers of glycols or polyglycols
#124Oligomeric phosphonates and compositions including the same
#125Hyperbranched oligomeric phosphonates and compositions including the same
#126Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
#127Polypeptide immobilization
#128LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE
#129Buffer compounds
#130METHODS FOR THE PREPARATION OF [2-(8,9-DIOXO-2,6-DIAZABICYCLO[5.2.0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID AND PRECURSORS THEREOF
#131Polyfluoroalkylphosphonic acid ester and process for producing the same
#132Diphenyl sulfide derivatives and medicines containing same as active ingredient
#133Multimodal imaging of fibrin
#134Phosphonate ester derivatives and methods of synthesis thereof
#135MAO-B INHIBITORS USEFUL FOR TREATING OBESITY
#136Plasma Carboxypeptidase B Inhibitors
#137Polyfluoroalkylphosphonic acid, method for producing the same and mold-releasing agent comprising the same as active ingredient
#138Redox shuttles for high voltage cathodes
#139NOVEL PYRROLE DERIVATIVES AND THEIR SYNTHESIS
#140Method of making hydroxymethylphosphonate
#141Contrast agents endowed with high relaxivity
#142Method for the production of alkylphosphonic acids, esters, and salts by oxidizing alkylphosphonous acids, and use thereof
#143Hydrophosphorylation of phosphonous acid derivatives for flame retardants
#144ORGANIC-INORGANIC COMPOSITE PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, AND METHOD FOR PRODUCING ORGANIC-INORGANIC COMPOSITE PARTICLES
#145Intermediates for hydroxylated contrast enhancement agents
#146USE OF STRUCTURED WATER-SOLUBLE POLYMERS OBTAINED BY CONTROLLED RADICAL POLYMERIZATION AS A DISPERSANT AND AGENT FOR ASSISTING IN THE GRINDING OF MINERAL MATERIALS
#147DIARYL ALKYLPHOSPHONATES AND METHODS FOR PREPARING SAME
#148Use of benzotropolone derivatives as UV absorbers and antioxidants and their use in sunscreens and/or cosmetic compositions
#149Selective caspase inhibitors and uses thereof
#150Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method
#151PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS
#152Process for preparing alkoxyamines resulting from β-phosphorated nitroxides
#153Process for producing phosphorus-containing dehydroamino acid
#154Mesoporous and nanoporous materials, and methods of synthesizing the same
#155PROCESS FOR PREPARING DIISOPROPYL((1-(HYDROXYMETHYL)-CYCLOPROPYL)OXY)METHYLPHOSPHONATE
#156Halogenated phosphonates, processes for their preparation and their use as flame retardants
#157Production of organic solvent solutions of rare-earth organophosphates
#158Poly(ethylene glycol) containing chemically disparate endgroups
#159ORGANOPHOSPHONATE OLIGOMERS
#160Alpha-chloro and alpha-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof
#161Substituted phosphonates and their use in decreasing amyloid aggregates
#162Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use
#163Process for making dihydrocarbyl hydrocarbonphosphonates
#164METHODS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HEXAHYDROFURO [2,3-B]FURAN-3-OL
#165MAO-B inhibitors useful for treating obesity
#166Process for preparing intermediates of HMG-CoA reductase inhibitors
#167Poly(ethylene glycol) containing chemically disparate endgroups
#168Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
#169Process for the preparation of chymase modulators
#170Process for preparing an alkenylphosphonic acid derivative
#171Alkyl H-phosphonates of N,N′-dialkylimidazoliums and of quaternary ammoniums and uses thereof
#172β-hydroxy-γ-aminophosphonates and methods for the preparation and use thereof
#173Novel Phosphorus-Containing Thyromimetics
#174BUTYRYLCHOLINESTERASE INHIBITORS
#175Synthetic lung surfactant and use thereof
#176Methods for synthesis of acyloxyalkyl compounds
#177Polypeptide Protracting Tags
#178Anti-Inflammatory and Anti-Allergy Extracts from Nettle
#1799-substituted minocycline compounds
#180Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines
#181NOVEL ALKOXYAMINES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN RADICAL
#182Synthesis of phosphonic acid labeled compounds
#183Fluorine-containing copolymer
#184ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
#185METHOD FOR PREPARING ALKOXYAMINES BY PHOTOLYSIS OF DITHIOCARBAMATES
#186Process for preparing intermediates of HMG-CoA reductase inhibitors
#187PROCESS FOR THE CONTROLLED RADICAL POLYMERIZATION OR COPOLYMERIZATION OF ONE OR MORE MONOMERS IN THE PRESENCE OF AN INITIATOR OF ALKOXYAMINE TYPE
#188Diaryl alkylphosphonates and methods for preparing same
#189Process for preparing diisopropyl((1-(hydroxymethyl)-cyclopropyl)oxy)methylphosphonate
#190USE OF PARTICULAR POLYMERS OR COPOLYMERS AS SURFACTANTS FOR STABILIZING LATICES
#191Sterically hindered phenolic phosphonates and polycarbonate resin composition using the same
#192Aryl amide sphingosine 1-phosphate analogs
#193PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#194Process for synthesizing phosphonic and phosphinic acid compounds
#195Phosphorus-containing thyromimetics
#196Purification of rosuvatatin intermediate by thin film evaporation and chemical method
#197Optically Active Alpha-Hydroxyphosphonic Acid, Its Derivatives and Production Method thereof, Optically Active Aluminum (Salalen) Complex and Production Method Thereof, and Production Method of Salalen Ligand
#198Functionalized carbon nanotubes, recovery of radionuclides and separation of actinides and lanthanides
#199Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution
#200Plasma carboxypeptidase B inhibitors
#201Rosuvastatin intermediates and process for the preparation of rosuvastatin
#202Process for preparing intermediates of HMG-CoA reductase inhibitors
#203Rosuvastatin intermediates and their preparation
#204Process for preparing phosponates having alcoholic hydroxyl group
#205Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds
#206Novel inhibitors of chymase
#207Sphingosine-1-phosphate receptor agonist and antagonist compounds
#208Urokinase inhibitors
#209Organophosphoric derivatives useful as anti-parasitic agents
#210Compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of α-perfluoroalkylamine compounds
#211Method for Synthesizing Long-Chain Phosphonic Acid Derivatives and Thiol Derivatives
#212Aminophenylpropanoic acid derivative
#213Process for the Preparation of the Alkoxyamine 2-Methyl-2-[N-(Diethoxyphosphoryl-2,2-Dimethylpropyl)-Aminoxy] Propionic Acid
#214Poly(ethylene glycol) containing chemically disparate endgroups
#215CROSSLINKERS CONTAINING PHOSPHOROUS
#216MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity
#217Stabilized sulforaphane
#218ANTI-INFECTIVE PHOSPHONATE ANALOGS
#219Protein tyrosine phosphatase inhibitors and methods of use thereof
#220Fluorine-containing polyether phosphonic acid ester compound and process for producing the same
#221LPA receptor agonists and antagonists and methods of use
#222Telomer compositions and production processes
#223Polypeptide immobilization
#224Method for preparing prostaglandin derivative
#225Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#226Process for preparation of HIV protease inhibitors
#227Inhibitors of β-lactamase
#228Naphthalene compounds as selective estrogen receptor modulators
#229Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
#230Process for the preparation of pyridine derivatives
#231Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#232Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use
#233Diaryl alkylphosphonates and methods for preparing same
#234Method and compositions for identifying anti-hiv therapeutic compounds
#235Use of structured water-soluble polymers obtained by controlled radical polymerization as a dispersant and agent for assisting in the grinding of mineral materials
#236ALKOXYAMINES DERIVED FROM BETA-PHOSPHORYLATED NITROXIDES, AND USE THEREOF FOR PREPARING POLYMERIZED OR NON-POLYMERIZED MONO- OR POLYALKOXYAMINES
#2373-(4-benzyloxyphenyl) propanoic acid derivatives
#238Production method for aminophosphonic acid derivatives
#239Analogs of lysophosphatidic acid and methods of making and using thereof
#240Glycero-compound having triple bond and membrane material containing the same
#241MAO-B inhibitors useful for treating obesity
#242Methods and compositions for mitigating pain
#243Substituted phosphonate fluorescent sensors and use thereof
#244Diaryl alkylphosphonates and method for preparing same
#245Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#246Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#247MAO-B inhibitors useful for treating obesity
#248Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX
#249Fuel cell membrane containing zirconium phosphate
#250Phosphonium and imidazolium salts and methods of their preparation
#251Therapeutic phosphonate compounds
#252Plasma carboxypeptidase B inhibitors
#253Anti-inflammatory phosphonate compounds
#254Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete
#255Alkoxyamines originating from β-phoshorated nitroxides and use thereof in radical polymerisation
#256Protein tyrosine phosphatase inhibitors and methods of use thereof
#257Compounds for forming photoconvertible organic thin film and organic thin film formed body
#258Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
#259Non nucleoside reverse transcriptase inhibitors
#260Compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-α-perfluoroalkylamines
#261Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#262Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
#263Method and compositions for identifying anti-hiv therapeutic compounds
#264(+)-Ttrans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl)methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
#265Novel inhibitors of beta-lactamase
#2664-Dedimethylamino tetracycline compounds
#267Chelating agents for heavy metal removal
#268Peptide deformylase activated prodrugs
#269Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#270Phosphorus-containing thyromimetics
#271Preparation of polyphosonates via transesterification without a catalyst
#272LPA receptor agonists and antagonists and methods of use
#273Pyrimidyl phosphonate antiviral compounds and methods of use
#274Organophosphorus compounds having polysulfide bridge
#275Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#276Method and compositions for identifying anti-HIV therapeutic compounds
#277Amino phosphonate and amino bis-phosphonate derivatives
#278Multilayer acrylic film with improved optical and mechanical properties
#279Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
#280Anti-infective phosphonate analogs
#281Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#282Preparation of halohydrocarbyl phosphonic acid diesters
#283Non nucleoside reverse transcriptase inhibitors
#284Inhibitors of chymase
#285Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
#286Nitrate esters and their use for mitigating cellular damage
#287Prodrugs activated by targeted catalytic proteins
#288Process for the preparation of polyalkoxyamines which can be used as initiators for the radical polymerization of polyfunctional living (CO)polymers
#289Novel lysophosphatidic acid receptor agonists and antagonists
#290Methods for synthesis of acyloxyalkyl compounds
#291Alkoxyamines derived from beta-phosphorylated nitroxides, and use thereof for preparing polymerized or non-polymerized mono- or polyalkoxyamines
#292Synthesis method for polymers by controlled radical polymerisation with xanthates
#293Inhibitors of β-lactamase
#294LTAhydrolase inhibitors